Natco Pharma Ltd.

BSE: 524816 | NSE: NATCOPHARM
Small Cap | Pharmaceuticals & Drugs
923.65
5.75 (0.63%)
< Home < Back

Natco Pharma informs about change in management

Date: 27-07-2024
Natco Pharma has informed that in accordance with the provisions of Regulation 30 read with Schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Sanivarapu Ravi Prakash Reddy, Senior Vice President - Operations, Pharma Division, Kothur, Rangareddy District, Telangana has resigned and relieved with effect from 25th July, 2024. The details as required under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 read with SEBI Circular No. SEBI/HO/CFD/CFDPoD1/P/CIR/2023/123 dated July 13, 2023, is as enclosed.

The above information is a part of company’s filings submitted to BSE.